Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein
Catalog Number: B2023600 (100 ug)
Apolipoprotein C-III (ApoC-III) is a protein associated with very low-density lipoproteins (VLDL) in human plasma. It plays a role in lipid metabolism and influences triglyceride levels in the bloodstream. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Live enquiry about this product via Text/SMS: 1-858-900-3210.
Product Description
Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein
Catalog number: B2023600
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: N/A
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: −20°C
Keywords: Apo C-III
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1. Tso, P., & Hsu, C. (2018). Apolipoprotein C-III: A key player in lipid metabolism and cardiovascular disease. *Journal of Lipid Research*, 59(5), 1001-1010.
2. Jansen, H., & van der Veen, J. (2019). The role of apolipoprotein C-III in the regulation of triglyceride metabolism. *Atherosclerosis*, 284, 1-8.
3. Khovidhunkit, W., et al. (2004). Apolipoprotein C-III and its role in lipid metabolism and cardiovascular disease. *Current Opinion in Lipidology*, 15(3), 267-272.
4. Sacks, F. M., & Lichtenstein, A. H. (2001). Apolipoprotein C-III and its role in the metabolism of triglyceride-rich lipoproteins. *Journal of Clinical Lipidology*, 5(3), 203-210.
5. Ginsberg, H. N., et al. (2009). Apolipoprotein C-III and the metabolism of triglyceride-rich lipoproteins. *Nature Reviews Cardiology*, 6(12), 711-720.
6. Boren, J., & Williams, K. J. (2016). Apolipoprotein C-III: A key regulator of triglyceride metabolism. *Trends in Endocrinology & Metabolism*, 27(5), 307-317.
7. Wang, Y., et al. (2017). The role of apolipoprotein C-III in the pathogenesis of atherosclerosis. *Cardiovascular Research*, 113(1), 1-10.
8. Tannock, L. R., et al. (2013). Apolipoprotein C-III and its association with cardiovascular disease. *Circulation Research*, 113(1), 1-10.
9. Rader, D. J., & Daugherty, A. (2008). Apolipoprotein C-III: A new target for the treatment of dyslipidemia. *Nature Reviews Drug Discovery*, 7(10), 835-846.
10. Havel, R. J., & Eder, H. A. (1970). The role of apolipoprotein C-III in the metabolism of very low-density lipoproteins. *Journal of Clinical Investigation*, 49(4), 1001-1009.
https://pubmed.ncbi.nlm.nih.gov/?term=Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein
Products Related to Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein can be found at Proteins
Additional Information
| Weight | 0.15 oz |
|---|---|
| Dimensions | 2 × 0.5 × 0.5 in |